Endotracheal Surfactant Combined With Budesonide for Neonatal ARDS
Acute respiratory distress syndrome (ARDS) is a clinical condition characterized by acute diffuse inflammatory lung injury and severe hypoxemia. In 2017, the Montreux Consensus defined diagnostic criteria for ARDS in the neonatal period. The management of ARDS includes strict adherence to lung-prote...
Saved in:
Main Authors: | Burak Deliloglu (Author), Funda Tuzun (Author), Merve Meryem Cengiz (Author), Hasan Ozkan (Author), Nuray Duman (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Volume Guarantee High-Frequency Oscillatory Ventilation in Preterm Infants With RDS: Tidal Volume and DCO2 Levels for Optimal Ventilation Using Open-Lung Strategies
by: Funda Tuzun, et al.
Published: (2020) -
Acute Pathophysiological Effects of Intratracheal Instillation of Budesonide and Exogenous Surfactant in a Neonatal Surfactant-depleted Piglet Model
by: Chia-Feng Yang, et al.
Published: (2010) -
Effect of Surfactant and Budesonide on the Pulmonary Distribution of Fluorescent Dye in Mice
by: Liang-Ti Huang, et al.
Published: (2015) -
Surfactant-Assisted Distal Pulmonary Distribution of Budesonide Revealed by Mass Spectrometry Imaging
by: Riccardo Zecchi, et al.
Published: (2021) -
Biophysical and chemical stability of surfactant/budesonide and the pulmonary distribution following intra-tracheal administration
by: Chung-Ming Chen, et al.
Published: (2019)